Aortic insufficiency stages: Difference between revisions
(→Stages) |
(→Stages) |
||
Line 10: | Line 10: | ||
Shown below is a table summarizing the stages of [[aortic regurgitation]] (AR) according to the 2014 AHA/ACC guidelines for the management of patients with [[valvular heart disease]]. <ref>{{Cite web | last = | first = | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.full.pdf+html | publisher = | date = | accessdate = 4 March 2014 }}</ref> | Shown below is a table summarizing the stages of [[aortic regurgitation]] (AR) according to the 2014 AHA/ACC guidelines for the management of patients with [[valvular heart disease]]. <ref>{{Cite web | last = | first = | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.full.pdf+html | publisher = | date = | accessdate = 4 March 2014 }}</ref> | ||
<span style="font-size:85%">'''Abbreviations:''' '''AR''': aortic regurgitation; '''ERO''': effective regurgitant orifice; '''HF''': heart failure; '''IE''': infective endocarditis; '''LV''': left ventricular; '''LVEF''': left ventricular ejection fraction; '''LVESD''': left ventricular end-systolic dimension; '''LVOT''': left ventricular outflow tract; '''RF''': regurgitant fraction; '''RVol''': regurgitant volume </span> | <span style="font-size:85%">'''Abbreviations:''' '''AR''': aortic regurgitation; '''ERO''': effective regurgitant orifice; '''HF''': heart failure; '''IE''': infective endocarditis; '''LV''': left ventricular; '''LVEF''': left ventricular ejection fraction; '''LVESD''': left ventricular end-systolic dimension; '''LVOT''': left ventricular outflow tract; '''RF''': regurgitant fraction; '''RVol''': regurgitant volume; '''Jet/LVOT''' : jet width and LVOT ratio</span> | ||
{| class="wikitable" | {| class="wikitable" |
Revision as of 18:54, 8 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
According to the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease, aortic insufficiency has 4 stages based on the valve's anatomy and hemodynamics and the patients symptoms.
Stages
Shown below is a table summarizing the stages of aortic regurgitation (AR) according to the 2014 AHA/ACC guidelines for the management of patients with valvular heart disease. [1]
Abbreviations: AR: aortic regurgitation; ERO: effective regurgitant orifice; HF: heart failure; IE: infective endocarditis; LV: left ventricular; LVEF: left ventricular ejection fraction; LVESD: left ventricular end-systolic dimension; LVOT: left ventricular outflow tract; RF: regurgitant fraction; RVol: regurgitant volume; Jet/LVOT : jet width and LVOT ratio
STAGE | DEFINITION | VALVE ANATOMY | VALVE HEMODYNAMICS | HEMODYNAMIC CONSEQUENCES | SYMPTOMS |
---|---|---|---|---|---|
A | At risk of AR | ❑ Bicuspid valve ❑ Valve sclerosis ❑ History of rheumatic fever ❑ Infective endocarditis |
❑ None | ❑ None | ❑ None |
B | Progressive AR | ❑ Mild-to-moderate calcification ❑ Rheumatic valve changes
|
❑ Mild AR:
|
❑ Normal LV systolic function ❑ Normal LV volume or mild LV dilation |
❑ None |
C | Asymptomatic severe AR | ❑ Calcific aortic valve disease ❑ Rheumatic valve changes ❑ Bicuspid valve ❑ Dilated aortic sinuses ❑ Infective endocarditis with abnormal leaflet closure |
❑ Severe AR
|
❑ C1: Normal LVEF and mild to moderate LV dilatation ❑ C2: abnormal LV systolic function with decreased LVEF or severe LV dilatation |
❑ None ❑ Exercise testing to confirm symptom status |
D | Symptomatic severe AR | ❑ Calcific aortic valve disease ❑ Rheumatic valve changes
|
❑ Severe AR
|
❑ May occur with normal systolic function or decreased function ❑ Presence of moderate to severe LV dilatation |
❑ Exertional dyspnea ❑ Exertional angina ❑ HF symptoms
|
References
- ↑ "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary". Retrieved 4 March 2014.